Israel Englander’s OpGen, Inc OPGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-57
Closed -$2K 7060
2022
Q4
$2K Buy
+57
New +$2.1K ﹤0.01% 6417
2022
Q3
Sell
-121
Closed -$13K 7627
2022
Q2
$13K Sell
121
-729
-86% -$79.4K ﹤0.01% 6606
2022
Q1
$127K Sell
850
-338
-28% -$59.2K ﹤0.01% 6038
2021
Q4
$238K Buy
+1,188
New +$392K ﹤0.01% 5761
2021
Q3
Sell
-176
Closed -$80K 7386
2021
Q2
$80K Buy
+176
New +$80.5K ﹤0.01% 6286
2021
Q1
Sell
-110
Closed -$45K 6616
2020
Q4
$45K Buy
+110
New +$45.6K ﹤0.01% 5094
2020
Q2
Sell
-358
Closed -$183K 4711
2020
Q1
$183K Sell
358
-173
-33% -$72.3K ﹤0.01% 3419
2019
Q4
$120K Buy
+531
New +$278K ﹤0.01% 3996

Other funds holding OPGN

Israel Englander's OPGN Position: Q1 2023 in Review

Israel Englander sold out of OpGen, Inc (OPGN) in Q1 2023, closing a stake of 57 shares — an estimated $2K sold.

Israel Englander first reported a position in OPGN in Q4 2019 and held it in 8 quarters. The position peaked at $238K in Q4 2021. 15 funds tracked by Wall St. Rank hold OPGN as of Q1 2023.

  • Israel Englander reported no remaining OpGen, Inc position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 57 OpGen, Inc shares in Q1 2023, an estimated $2K.
  • Israel Englander first reported a position in OpGen, Inc in Q4 2019 and held it in 8 quarters.
  • Israel Englander's OpGen, Inc position peaked at $238K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held OpGen, Inc as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.